Suchergebnisse - "Minassian, Angela M"

PubPharm (74)

11

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial

enthalten in: NPJ vaccines | 2024

von Martinez, F. | White, M. | Guillotte-Blisnick, M. | +15

12

A systematic analysis of the human immune response to Plasmodium vivax

enthalten in: The Journal of clinical investigation | 2023

von Bach, F. | Muñoz Sandoval, D. | Mazurczyk, M. | +13

13

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

enthalten in: Med (New York, N.Y.) | 2023

von Silk, S. | Kalinga, W. | Mtaka, I. | +31

14

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

enthalten in: bioRxiv.org | 2023

von Wang, L. | Cooper, A. | Farrell, B. | +30

15

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

enthalten in: bioRxiv.org | 2023

von Barrett, J. | Pipini, D. | Wright, N. | +37

16

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3) : A randomised controlled trial

enthalten in: The Journal of infection | 2023

von Kelly, E. | Greenland, M. | de Whalley, P. | +31

17

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Wright, A. | +59

18

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

enthalten in: Science translational medicine | 2023

von Hou, M. | Barrett, J. | Themistocleous, Y. | +33

UpdateOf: medRxiv. 2022 May 30;:. - PMID 35664997

19

Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies

enthalten in: Malaria journal | 2023

von Miura, K. | Diouf, A. | Fay, M. | +7

20

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Feng, S. | +56

ErratumFor: J Infect. 2022 Jun;84(6):795-813. - PMID 35405168